ORAMA THERAPEUTICS LTD
Significant control: Cs Pharmaceuticals Ltd (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Orama Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Orama Therapeutics Ltd sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ORAMA THERAPEUTICS LTD is an active private limited company (company number 15612953) incorporated on 3 April 2024, registered in London. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest dormant accounts cover the period ending 30 April 2025, showing net assets of £1.
By net assets it sits in the lower half of 76 comparable companies in London (median £100, upper quartile £88k).
Ownership and control
- Cs Pharmaceuticals Ltd
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 3 April 20242 yrs ago
- Next accounts due
- 30 January 2027in 94 days
- Confirmation statement due
- 17 April 2027in 171 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 46460
- Wholesale of pharmaceutical goods
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | £1 | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £1 at 30 April 2025
- Incorporated two to five years agoIncorporated 3 April 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 171 days
- Next accounts duein 94 days
- Accounts period endNet assets £1 · dormant accounts
- Incorporated
Similar companies in London
- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLCLondon · inc. Apr 2024
- D-GRACE LIMITEDLondon · inc. Mar 2024
- ASPEYA UK LIMITEDLondon · inc. May 2024
- MIDLAND PHARMACEUTICALS LTDLondon · inc. Feb 2024
- ALIOAURORACEL LIMITEDLondon · inc. Jun 2024
- HEALTH AND BEAUTY LAB LTDLondon · inc. Jan 2024
All companies incorporated on 3 April 2024 · in Apr 2024.
Reminders for ORAMA THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.